End-of-day quote
Taipei Exchange
06:00:00 2024-04-25 pm EDT
|
5-day change
|
1st Jan Change
|
9.84
TWD
|
-1.50%
|
|
-1.50%
|
-12.53%
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Capitalization
1 |
11,401
|
3,856
|
1,819
|
2,189
|
9,882
|
2,735
|
Enterprise Value (EV)
1 |
11,553
|
3,889
|
1,904
|
2,746
|
10,076
|
2,959
|
P/E ratio
|
81.2
x
|
-35
x
|
-6.62
x
|
-6.82
x
|
-20.1
x
|
-5.8
x
|
Yield
|
0.28%
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
3.5
x
|
2.07
x
|
2.08
x
|
3.79
x
|
18.1
x
|
8.07
x
|
EV / Revenue
|
3.55
x
|
2.09
x
|
2.17
x
|
4.76
x
|
18.4
x
|
8.73
x
|
EV / EBITDA
|
49.8
x
|
-58.9
x
|
-9.47
x
|
-26.2
x
|
-49.8
x
|
-8.06
x
|
EV / FCF
|
23.5
x
|
13.2
x
|
8.18
x
|
-7.93
x
|
-98.1
x
|
-13.6
x
|
FCF Yield
|
4.25%
|
7.55%
|
12.2%
|
-12.6%
|
-1.02%
|
-7.33%
|
Price to Book
|
6.78
x
|
2.62
x
|
1.58
x
|
2.6
x
|
11.1
x
|
5.78
x
|
Nbr of stocks (in thousands)
|
144,761
|
145,498
|
145,303
|
145,961
|
170,961
|
172,031
|
Reference price
2 |
78.76
|
26.50
|
12.52
|
15.00
|
57.80
|
15.90
|
Announcement Date
|
4/27/18
|
4/30/19
|
4/30/20
|
4/29/21
|
5/3/22
|
5/2/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net sales
1 |
3,259
|
1,863
|
876.6
|
577.4
|
546.8
|
339.1
|
EBITDA
1 |
232.2
|
-65.98
|
-201.1
|
-104.9
|
-202.4
|
-367.3
|
EBIT
1 |
209.2
|
-93.82
|
-240.3
|
-173.1
|
-271.7
|
-470.3
|
Operating Margin
|
6.42%
|
-5.04%
|
-27.41%
|
-29.98%
|
-49.69%
|
-138.68%
|
Earnings before Tax (EBT)
1 |
172.4
|
-99.81
|
-265.2
|
-307.7
|
-441.8
|
-489.2
|
Net income
1 |
141.2
|
-109.6
|
-274.1
|
-320.3
|
-439.4
|
-470.4
|
Net margin
|
4.33%
|
-5.88%
|
-31.27%
|
-55.47%
|
-80.35%
|
-138.71%
|
EPS
2 |
0.9700
|
-0.7571
|
-1.890
|
-2.200
|
-2.872
|
-2.741
|
Free Cash Flow
1 |
491.4
|
293.5
|
232.7
|
-346.3
|
-102.7
|
-216.8
|
FCF margin
|
15.08%
|
15.76%
|
26.54%
|
-59.98%
|
-18.78%
|
-63.94%
|
FCF Conversion (EBITDA)
|
211.66%
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
348%
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
0.2200
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/27/18
|
4/30/19
|
4/30/20
|
4/29/21
|
5/3/22
|
5/2/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net Debt
1 |
152
|
33.5
|
85.1
|
557
|
195
|
224
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
0.6531
x
|
-0.507
x
|
-0.4233
x
|
-5.31
x
|
-0.9627
x
|
-0.609
x
|
Free Cash Flow
1 |
491
|
294
|
233
|
-346
|
-103
|
-217
|
ROE (net income / shareholders' equity)
|
9.32%
|
-6.96%
|
-20.9%
|
-32.1%
|
-50.7%
|
-69.3%
|
ROA (Net income/ Total Assets)
|
3.92%
|
-1.91%
|
-6.09%
|
-5.2%
|
-9%
|
-17.9%
|
Assets
1 |
3,600
|
5,737
|
4,503
|
6,162
|
4,881
|
2,627
|
Book Value Per Share
2 |
11.60
|
10.10
|
7.920
|
5.770
|
5.210
|
2.750
|
Cash Flow per Share
2 |
4.580
|
3.850
|
4.250
|
0.6700
|
1.920
|
1.390
|
Capex
1 |
43.4
|
100
|
131
|
269
|
202
|
105
|
Capex / Sales
|
1.33%
|
5.39%
|
14.89%
|
46.63%
|
36.97%
|
31.06%
|
Announcement Date
|
4/27/18
|
4/30/19
|
4/30/20
|
4/29/21
|
5/3/22
|
5/2/23
|
|
1st Jan change
|
Capi.
|
---|
| -12.53% | 51.59M | | +11.47% | 63.22B | | -3.47% | 46.34B | | +13.72% | 39.97B | | +17.83% | 25.46B | | +7.27% | 18.68B | | -0.57% | 17.24B | | -21.73% | 15.81B | | +0.22% | 14.9B | | -19.10% | 13.74B |
Other Specialty Chemicals
|